Login
Super Investors Ulys, L.L.C.
UL

Ulys, L.L.C.

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$25.4M
Positions
1
Quarter ended
March 31, 2021
Filed
May 14, 2021

Reported portfolio value by quarter (32 quarters reported)

$78.1M $6.22M
Q2 13 Q1 15 Q4 16 Q3 18 Q2 20 Q1 21

$64.7M in Q2 2013 → $25.4M now. Hover for any quarter.

Holdings

As reported for the quarter ended March 31, 2021. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Lexicon Pharmaceuticals Inc 100.0% Unchanged 4,321,214 $25.4M

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q1 2021

quarter ended March 31, 2021 · filed May 14, 2021

No position changes this quarter.

Q4 2020

quarter ended December 31, 2020 · filed February 11, 2021

No position changes this quarter.

Q3 2020

quarter ended September 30, 2020 · filed November 13, 2020

No position changes this quarter.

Q2 2020

quarter ended June 30, 2020 · filed August 14, 2020

No position changes this quarter.

Q1 2020

quarter ended March 31, 2020 · filed May 14, 2020

No position changes this quarter.

Q4 2019

quarter ended December 31, 2019 · filed February 13, 2020

No position changes this quarter.

Q3 2019

quarter ended September 30, 2019 · filed November 14, 2019

No position changes this quarter.

Q2 2019

quarter ended June 30, 2019 · filed August 09, 2019

No position changes this quarter.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support